Omnia Sana · Plant Monograph
Saw Palmetto
Serenoa repens
This monograph compiles 2 documented constituents, 3 traditional / indicated uses, supported by 13 cited sources, drawn directly from the Omnia Sana plant database.
Key Constituents
Traditional & Indicated Uses
Lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - widely used, but high-quality Cochrane evidence shows it is NOT better than placebo, even at double and triple doses
more plants for prostate support →detailed sources →General urinary support (traditional); Lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - widely used, but high-quality Cochrane evidence shows it is NOT better than placebo, even at double and triple doses
more plants for urinary support →detailed sources →Lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - widely used, but high-quality Cochrane evidence shows it is NOT better than placebo, even at double and triple doses
more plants for urinary tract infection (uti) →detailed sources →Safety, Cautions & Contraindications
Generally well tolerated; mild gastrointestinal upset is the most common effect. BPH must be medically diagnosed (to exclude prostate cancer), and because the best evidence does not show benefit, saw palmetto should not replace proven treatment.
Has mild anti-androgen and antiplatelet effects, so use caution with anticoagulant medicines and before surgery; avoid in pregnancy (hormonal activity).
References
REF-0571, REF-0572, REF-1887, REF-1888, REF-1889, REF-1890, REF-1891, REF-1892, REF-1893, REF-1894, REF-1895References & Sources
- Vela-Navarrete, R., Alcaraz, A., Rodriguez-Antolin, A., Minana Lopez, B., Fernandez-Gomez, J.M. and others (2018) 'Efficacy and safety of a hexanic extract of Serenoa repens (Permixon) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies', BJU International, 122(6), pp. 1049--1065. doi:10.1111/bju.14362 Meta-analysis / review
https://doi.org/10.1111/bju.14362 - Novara, G., Giannarini, G., Alcaraz, A., Cozar-Olmo, J.M., Descazeaud, A., Montorsi, F. and Ficarra, V (2016) 'Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials', European Urology Focus, 2(5), pp. 553--561. doi:10.1016/j.euf.2016.04.002 Meta-analysis / review
https://doi.org/10.1016/j.euf.2016.04.002 - Franco, J.V., Trivisonno, L., Sgarbossa, N.J., Alvez, G.A., Fieiras, C., Escobar Liquitay, C.M. and Jung, J.H (2023) 'Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement', Cochrane Database of Systematic Reviews, 6(6), pp. CD001423. doi:10.1002/14651858.CD001423.pub4 Meta-analysis / review
https://doi.org/10.1002/14651858.CD001423.pub4 - Ooi, S.L. and Pak, S.C (2017) 'Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine', Journal of Alternative and Complementary Medicine, 23(8), pp. 599-606. doi:10.1089/acm.2016.0302 Meta-analysis / review
https://doi.org/10.1089/acm.2016.0302 - Cai, T., Cui, Y., Yu, S., Li, Q., Zhou, Z. and Gao, Z (2020) 'Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis', American Journal of Men's Health, 14(2), pp. 1557988320905407. doi:10.1177/1557988320905407 Meta-analysis / review
https://doi.org/10.1177/1557988320905407 - Trivisonno, L.F., Sgarbossa, N., Alvez, G.A., Fieiras, C., Escobar Liquitay, C.M., Jung, J.H. and Franco, J.V.A (2021) 'Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis', Investigative and Clinical Urology, 62(5), pp. 520-534. doi:10.4111/icu.20210254 Meta-analysis / review
https://doi.org/10.4111/icu.20210254 - Kwon, Y (2019) 'Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia', Food Science and Biotechnology, 28(6), pp. 1599-1606. doi:10.1007/s10068-019-00605-9 Meta-analysis / review
https://doi.org/10.1007/s10068-019-00605-9 - MacDonald, R., Tacklind, J.W., Rutks, I. and Wilt, T.J (2012) 'Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review', BJU International, 109(12), pp. 1756-1761. doi:10.1111/j.1464-410X.2012.11172.x Meta-analysis / review
https://doi.org/10.1111/j.1464-410X.2012.11172.x - Minutoli, L., Bitto, A., Squadrito, F., Marini, H., Irrera, N., Morgia, G., Passantino, A. and Altavilla, D (2013) 'Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia', Current Medicinal Chemistry, 20(10), pp. 1306-1312. doi:10.2174/0929867311320100007 Meta-analysis / review
https://doi.org/10.2174/0929867311320100007 - Boyle, P., Robertson, C., Lowe, F. and Roehrborn, C (2004) 'Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia', BJU International, 93(6), pp. 751-756. doi:10.1111/j.1464-410X.2003.04735.x Meta-analysis / review
https://doi.org/10.1111/j.1464-410X.2003.04735.x - Willetts, K.E., Clements, M.S., Champion, S., Ehsman, S. and Eden, J.A (2003) 'Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial', BJU International, 92(3), pp. 267-270. doi:10.1046/j.1464-410x.2003.04316.x Randomized trial
https://doi.org/10.1046/j.1464-410x.2003.04316.x - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology. Randomized trial
Find this source - Tacklind, J., Macdonald, R., Rutks, I., Stanke, J.U. and Wilt, T.J (2012) 'Serenoa repens for benign prostatic hyperplasia', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001423.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD001423.pub3
Generated June 22, 2026 from omniasana.bio